Internal Medicine · Fresno, CA
NPI
1003908591
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
7061 N Whitney, Suite 101
Fresno, CA, 93720
Phone (559) 299-0224
Groups this clinician bills Medicare through
Medicare paid, 2024
$229K
3,473 services
Medicare patients, 2024
426
Average age 76
Drug cost, 2024
$1.8M
5,795 prescriptions
Company payments, 2025
$20K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John R Nelson was code 93000 (electrocardiogram), 962 times for 409 patients. In total John R Nelson billed 3,473 services in 17 codes, and Medicare paid $229K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 962 | 409 | $10.51 | $10K |
| 99214 Office E&M - Established | Office | 768 | 369 | $96.56 | $74K |
| 99213 Office E&M - Established | Office | 441 | 315 | $60.79 | $27K |
| 99211 Office E&M - Established | Office | 419 | 315 | $16.72 | $7,005 |
| 93306 Echocardiography (TTE/TEE) | Office | 300 | 291 | $143.60 | $43K |
| 78452 Myocardial Perfusion Scan | Office | 103 | 103 | $348.71 | $36K |
| 93922 Duplex Scan - Extremity Arteries | Office | 102 | 102 | $69.02 | $7,040 |
| 78468 Myocardial Perfusion Scan | Office | 102 | 102 | $122.20 | $12K |
| 93016 Electrocardiogram | Office | 69 | 69 | $16.49 | $1,138 |
| 93018 Electrocardiogram | Office | 68 | 68 | $10.85 | $738 |
| J0280 Injection, aminophyllin, up to 250 mg | Office | 47 | 47 | $6.08 | $286 |
| 93015 Electrocardiogram | Office | 40 | 39 | $50.61 | $2,024 |
| 99205 Office E&M - New | Office | 32 | 32 | $166.60 | $5,331 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 12 | 12 | $159.02 | $1,908 |
By year: 2022 $292K for 4,626 services; 2023 $272K for 4,058 services; 2024 $229K for 3,473 services.
Medicare prescription drug claims, 2024
In 2024, the drug John R Nelson prescribed most often to Medicare patients was Ezetimibe, with 932 prescriptions and refills. In total John R Nelson wrote 5,795 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ezetimibe Generic | 932 | 2,758 | 294 | $34K |
| Repatha Sureclick Evolocumab | 511 | 1,110 | 116 | $629K |
| Vascepa Icosapent Ethyl | 429 | 989 | 128 | $341K |
| Atorvastatin Calcium Generic | 414 | 1,215 | 121 | $4,593 |
| Metoprolol Succinate Generic | 393 | 1,122 | 116 | $6,439 |
| Icosapent Ethyl Generic | 332 | 853 | 119 | $136K |
| Rosuvastatin Calcium Generic | 251 | 745 | 76 | $3,570 |
| Amlodipine Besylate Generic | 233 | 684 | 76 | $1,541 |
| Nexlizet Bempedoic Acid/Ezetimibe | 177 | 389 | 51 | $154K |
| Pravastatin Sodium Generic | 159 | 474 | 54 | $2,041 |
| Carvedilol Generic | 110 | 310 | 31 | $1,105 |
| Valsartan Generic | 107 | 320 | 36 | $4,342 |
| Allopurinol Generic | 104 | 288 | 31 | $690 |
| Clopidogrel Clopidogrel Bisulfate | 103 | 309 | 39 | $1,165 |
| Olmesartan Medoxomil Generic | 96 | 288 | 33 | $2,302 |
Brand drugs: 1,554 claims; generic drugs: 4,241 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John R Nelson $20K ($20K in general payments such as food, travel and fees) from 10 companies. The largest payer was Amgen Inc. with $19K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 42 | $19K |
| Novartis Pharmaceuticals Corporation NVS | 14 | $196 |
| Esperion Therapeutics, Inc. ESPR | 5 | $144 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $133 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $99.51 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $40.5 |
| Ionis Pharmaceuticals, Inc. IONS | 2 | $39.72 |
| Abiomed JNJ | 1 | $30 |
| Chiesi USA, Inc. | 1 | $25.81 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $22.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.